MTSI MACOM Technology Solutions Holdings, Inc.
Semiconductors & Related Devices · Nasdaq · SEC CIK 1493594 · Fiscal year ends 10/03
Financial factors as of 2026-10-02 (2026Q4), TTM = sum of the last four quarters
Growth
TTM revenue YoY37.3%
TTM net income YoY718.4%
TTM EPS YoY690.4%
Revenue 3-yr CAGR27.0%
Net income 3-yr CAGR54.1%
Margins
Gross margin58.0%
Operating margin23.0%
Net margin25.3%
FCF margin22.0%
EBITDA margin26.8%
Returns
ROE22.2%
ROA15.1%
ROIC (approx.)14.4%
Asset turnover0.60x
Leverage & solvency
Liabilities / assets27.0%
Debt / equity0.20x
Current ratio2.53x
Interest coverage—
Cash quality & payout
Operating cash flow / net income1.07x
Accruals ratio-1.0%
Payout ratio—
Capex / revenue4.9%
Factor history charts and full statement history on Pro 🔒
Financial statements
| Line item | FY20262026-10-02 | FY20252025-10-03 |
|---|---|---|
| Income statement | ||
| Revenue | $1.33B | $967.26M |
| Cost of revenue | $557.23M | $438.26M |
| Gross profit | $770.40M | $529.00M |
| R&D expense | $285.83M | $244.47M |
| SG&A expense | $179.10M | $154.88M |
| Operating income | $305.47M | $129.65M |
| Interest expense | $6.33M | $5.52M |
| Pretax income | $389.89M | -$29.02M |
| Income tax | $54.63M | $25.18M |
| Net income | $335.25M | -$54.21M |
| EBITDA | $368.08M | $192.95M |
| EPS (basic) | 4.43 | -0.73 |
| EPS (diluted) | 4.31 | -0.73 |
| Weighted avg. shares (diluted) | 77.73M | 73.99M |
| Balance sheet | ||
| Cash & equivalents | $112.01M | $112.14M |
| Short-term investments | $680.40M | $673.83M |
| Receivables | $209.52M | $148.65M |
| Inventory | $284.31M | $237.84M |
| Current assets | $1.33B | $1.21B |
| PP&E, net | $251.96M | $230.29M |
| Goodwill | $335.70M | $336.31M |
| Intangibles | $57.92M | $78.57M |
| Total assets | $2.32B | $2.10B |
| Current liabilities | $522.89M | $325.12M |
| Short-term debt | $340.74M | $160.95M |
| Long-term debt | $0 | $339.63M |
| Total debt | $340.74M | $500.58M |
| Total liabilities | $626.18M | $776.26M |
| Shareholders' equity | $1.70B | $1.33B |
| Net debt | $228.73M | $388.43M |
| Shares outstanding | 76.38M | 74.48M |
| Cash flow statement | ||
| Operating cash flow | $357.09M | $235.37M |
| Capital expenditure | $64.42M | $42.55M |
| Free cash flow | $292.67M | $192.82M |
| Investing cash flow | -$147.93M | -$328.26M |
| Financing cash flow | -$209.16M | $58.10M |
| Depreciation & amortization | $62.61M | $63.30M |
| Stock-based compensation | $87.80M | $79.36M |
| Share buybacks | $56.94M | $43.13M |
Free plan shows the latest 2 periods; Pro shows all 17 🔒
· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.
Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-21 06:27.